Home > Balance Sheet > CIPLA

CIPLA
Total Non-Current Liabilities

    Back to Balance Sheet
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹61 Cr₹-31 Cr₹82 Cr₹184 Cr₹622 Cr

What is the latest Total Non-Current Liabilities ratio of CIPLA ?

The latest Total Non-Current Liabilities ratio of CIPLA is ₹61 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹61 Cr
Mar2025₹-31 Cr
Mar2024₹82 Cr
Mar2023₹184 Cr
Mar2022₹622 Cr

How is Total Non-Current Liabilities of CIPLA Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹61 Cr
Positive
Mar2025 ₹-31 Cr
Negative
Mar2024 ₹82 Cr
-55.36
Mar2023 ₹184 Cr
-70.48
Mar2022 ₹622 Cr -

Compare Total Non-Current Liabilities of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹111,173.5 Cr -1.5% 5.5% -6.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,785.0 Cr 0.4% -4.6% 6.9% Stock Analytics
DIVIS LABORATORIES ₹176,242.0 Cr 0.7% -1.1% 2.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,058.0 Cr 2.9% -1.2% 42.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,149.0 Cr 0.4% -0.6% 1.3% Stock Analytics
MANKIND PHARMA ₹97,952.3 Cr 0.7% -4% 1.9% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

-1.5%

5.5%

-6.5%

SENSEX

-0.5%

-4.3%

-8.4%


You may also like the below Video Courses